Chemotargets is a computationally-oriented biotech company focused on the discovery and development areas of small molecule pharmaceuticals and cosmeceuticals. Located in Barcelona, it was founded on March 2006 as a spin-off initiative from Dr. Mestres' Systems Pharmacology lab under the auspices of the Hospital del Mar Medical Research Institute (IMIM). Chemotargets’s goal is to help the pharmaceutical and cosmetics industry fast-forward the process of bringing new products to market, speeding up discovery and development programs and making them more cost-efficient. To this end, Chemotargets has designed, and continues to develop, the integrative CLARITY platform, involving a broad spectrum of cutting-edge computational methodologies and analytics tools.